Free Trial

Invesco Biotechnology & Genome ETF (PBE) Short Interest Ratio & Short Volume

Invesco Biotechnology & Genome ETF logo
$80.70 +0.31 (+0.39%)
As of 04:10 PM Eastern

Invesco Biotechnology & Genome ETF Short Interest Overview

As of April 15, 2026, Invesco Biotechnology & Genome ETF (PBE) had a short interest of 1,276 shares sold short, representing 0.04% of the public float. This marks a 937.40% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.2, meaning it would take 0.2 days of the average trading volume of 7,061 shares to cover all short positions.

Current Short Interest
1,276 shares
Previous Short Interest
123 shares
Change Vs. Previous Month
937.40%
Dollar Volume Sold Short
$103.76 thousand
Short Interest Ratio
0.2 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
3,110,000 shares
Short Percent of Float
0.04%
Today's Trading Volume
3,359 shares
Average Trading Volume
7,061 shares
Today's Volume Vs. Average
48%
Short Selling Invesco Biotechnology & Genome ETF?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

PBE Short Interest Over Time

PBE Days to Cover Over Time

PBE Percentage of Float Shorted Over Time

Invesco Biotechnology & Genome ETF Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20261,276 shares $103.76 thousand +937.4%0.0%0.23 $81.32
3/31/2026123 shares $9.74 thousand +173.3%0.0%0.02 $79.18
3/13/202645 shares $3.43 thousand -97.9%0.0%0 $76.18
2/27/20262,126 shares $174.29 thousand +38.7%0.1%0.48 $81.98
2/13/20261,533 shares $125.02 thousand -53.3%0.0%0.28 $81.55
1/30/20263,281 shares $268.62 thousand +27.9%0.1%0.32 $81.87
1/15/20262,565 shares $210.18 thousand -90.6%0.1%0.4 $81.94
12/31/202527,309 shares $2.24 million +23.3%0.9%3.32 $82.15
12/15/202522,155 shares $1.80 million -4.8%0.7%6.1 $81.11
11/28/202523,282 shares $1.94 million +2,153.8%0.7%2.6 $83.33
11/14/20251,033 shares $80.34 thousand -65.4%0.0%0.16 $77.77
10/31/20252,989 shares $223.67 thousand +0.9%0.1%0.81 $74.83
10/15/20253,000 shares $214.86 thousand +3.5%0.1%0.3 $71.62
9/30/20252,900 shares $202.62 thousand +163.6%N/A0.3 $69.87
9/15/20251,100 shares $76.56 thousand +57.1%N/A0.1 $69.60
8/31/2025700 shares $47.92 thousand +16.7%0.0%0.1 $68.45
8/15/2025600 shares $40.69 thousand -75.0%N/A0.1 $67.81
7/31/20252,400 shares $156.72 thousand -4.0%0.1%0.4 $65.30
7/15/20252,500 shares $163.45 thousand +78.6%N/A0.4 $65.38
6/30/20251,400 shares $89.74 thousand +180.0%0.0%0.2 $64.10
6/15/2025500 shares $31.97 thousand -50.0%0.0%0.1 $63.94
5/31/20251,000 shares $62.68 thousand -28.6%0.0%0.1 $62.68
5/15/20251,400 shares $85.18 thousand -26.3%N/A0.2 $60.84
4/30/20251,900 shares $118.33 thousand +216.7%N/A0.2 $62.28
4/15/2025600 shares $35.98 thousand -60.0%N/A0.1 $59.97
3/14/20252,100 shares $137.76 thousand +250.0%N/A0.3 $65.60
2/14/20256,700 shares $455.40 thousand +644.4%N/A1 $67.97
1/31/2025900 shares $62.42 thousand -30.8%N/A0.1 $69.36
1/15/20251,300 shares $88.76 thousand -35.0%N/A0.2 $68.28

PBE Short Interest - Frequently Asked Questions

What is Invesco Biotechnology & Genome ETF's current short interest?

Short interest is the volume of Invesco Biotechnology & Genome ETF shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,276 shares of PBE short. 0.04% of Invesco Biotechnology & Genome ETF's shares are currently sold short. Learn More on Invesco Biotechnology & Genome ETF's current short interest.

What is a good short interest ratio for Invesco Biotechnology & Genome ETF?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PBE shares currently have a short interest ratio of 0.2. Learn More on Invesco Biotechnology & Genome ETF's short interest ratio.

What is a good short interest percentage for Invesco Biotechnology & Genome ETF?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Invesco Biotechnology & Genome ETF's floating shares are currently sold short.

Is Invesco Biotechnology & Genome ETF's short interest increasing or decreasing?

Invesco Biotechnology & Genome ETF saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,276 shares, an increase of 937.4% from the previous total of 123 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Invesco Biotechnology & Genome ETF's short interest compare to its competitors?

0.04% of Invesco Biotechnology & Genome ETF's shares are currently sold short. Here is how the short interest of companies compare to Invesco Biotechnology & Genome ETF: Invesco Pharmaceuticals ETF (0.07%), ALPS Medical Breakthroughs ETF (0.83%), SPDR S&P Pharmaceuticals ETF (5.80%), VanEck Biotech ETF (0.33%), SPDR S&P Health Care Equipment ETF (16.88%), Invesco S&P SmallCap Health Care ETF (1.32%), Invesco Dorsey Wright Healthcare Momentum ETF (0.15%), Direxion Daily Healthcare Bull 3x Shares (2.96%), SPDR S&P Health Care Services ETF (39.57%), Direxion Daily S&P Biotech Bear 3x Shares (24.70%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short Invesco Biotechnology & Genome ETF stock?

Short selling PBE is an investing strategy that aims to generate trading profit from Invesco Biotechnology & Genome ETF as its price is falling. PBE shares are trading up $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Invesco Biotechnology & Genome ETF?

A short squeeze for Invesco Biotechnology & Genome ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PBE, which in turn drives the price of the stock up even further.

How often is Invesco Biotechnology & Genome ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBE, twice per month. The most recent reporting period available is April, 15 2026.

What do PBE's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like PBE:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.




This page (NYSEARCA:PBE) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners